Publications by authors named "Gordon Jayson"

Claim this Profile
O
Overall Survival for Bevacizumab Therapy in Metastatic Colorectal Cancer: An Updated Analysis of the TRAVASTIN Study.
Rosie Maye Solomon, Robert D Morgan, Laura Horsley, Kalena Marti-Marti, Danielle Shaw, Gordon C Jayson

Clin Colorectal Cancer· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Homologous recombination deficiency in unselected cases of high-grade ovarian carcinoma.
Robert D Morgan, George J Burghel, Joseph Shaw, Helene Schlecht, Debbie Baishnab, Gordon C Jayson

J Med Genet· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Participants' perspectives of the advanced ovarian cancer biomarker study VALTIVE1: a qualitative study.
Daniella Holland-Hart, Margherita Carucci, Magdalena Slusarczyk, Mirella Longo, Susan Campbell, Gordon Jayson

BMJ Open· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Germline BRCA1/2 status and chemotherapy response score in high-grade serous ovarian cancer.
Robert D Morgan, Xin Wang, Bethany M Barnes, Laura Spurgeon, Aurore Carrot, Gordon C Jayson

Br J Cancer· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Extended panel testing in ovarian cancer reveals BRIP1 as the third most important predisposition gene.
Robert D Morgan, George J Burghel, Nicola Flaum, Helene Schlecht, Andrew R Clamp, Gordon C Jayson

Genet Med· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The VALTIVE1 study protocol: a study for the validation of Tie2 as the first tumour vascular response biomarker for VEGF inhibitors.
Margherita Carucci, Andrew Clamp, Cong Zhou, Chris Hurt, Rosalind Glasspool, Gordon C Jayson

BMC Cancer· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Once daily cediranib and weekly paclitaxel to prevent malignant bowel obstruction in at-risk patients with platinum-resistant ovarian cancer (CEBOC): a single-arm, phase II safety trial.
Alexander D Murphy, Catharine Porter, Ann White, Alys Irving, Richard Adams, Gordon C Jayson

Int J Gynecol Cancer· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Results of a randomised Phase II trial of olaparib, chemotherapy or olaparib and cediranib in patients with platinum-resistant ovarian cancer.
Shibani Nicum, Naomi McGregor, Rachel Austin, Linda Collins, Susan Dutton, Gordon Jayson

Br J Cancer· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-World Concordance between Germline and Tumour Status in Epithelial Ovarian Cancer.
Robert D Morgan, George J Burghel, Helene Schlecht, Andrew R Clamp, Jurjees Hasan, Gordon C Jayson

Cancers (Basel)· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predicting the likelihood of a pathogenic variant being somatic by testing only tumour DNA in non-mucinous high-grade epithelial ovarian cancer.
Robert D Morgan, George J Burghel, Nicola Flaum, Michael Bulman, Philip Smith, Gordon C Jayson

J Clin Pathol· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Homologous recombination deficiency in newly diagnosed FIGO stage III/IV high-grade epithelial ovarian cancer: a multi-national observational study.
Robert D Morgan, Andrew R Clamp, Bethany M Barnes, Kirsten Timms, Helene Schlecht, Gordon C Jayson

Int J Gynecol Cancer· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multi-Maintenance Olaparib Therapy in Relapsed, Germline BRCA1/2-Mutant High-Grade Serous Ovarian Cancer (MOLTO): A Phase II Trial.
Robert D Morgan, Andrew R Clamp, Daniel J White, Marcus Price, George J Burghel, Gordon C Jayson

Clin Cancer Res· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unexpected Diastereomer Formation and Interconversions in Cyclohexane-1,2-diacetal Derivatization of a Glucuronic Acid Thioglycoside.
Fahad Ayesh Alharthi, Garrett T Potter, Gordon C Jayson, George F S Whitehead, Iñigo J Vitórica-Yrezábal

Org Lett· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Is Reflex Germline Testing Necessary in Women Diagnosed with Non-Mucinous High-Grade Epithelial Ovarian Cancer Aged 80 Years or Older?
Robert D Morgan, George J Burghel, Nicola Flaum, Michael Bulman, Philip Smith, Gordon C Jayson

Cancers (Basel)· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Home Parenteral Nutrition in Patients with Advanced Cancer: Quality Outcomes from a Centralized Model of Care Delivery.
Maja Kopczynska, Antje Teubner, Arun Abraham, Michael Taylor, Ashley Bond, Gordon C Jayson

Nutrients· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BRCA1/2 in non-mucinous epithelial ovarian cancer: tumour with or without germline testing?
Robert D Morgan, George J Burghel, Nicola Flaum, Michael Bulman, Philip Smith, Gordon C Jayson

Br J Cancer· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A first-in-human Phase I dose-escalation trial of the novel therapeutic peptide, ALM201, demonstrates a favourable safety profile in unselected patients with ovarian cancer and other advanced solid tumours.
Aya El Helali, Ruth Plummer, Gordon C Jayson, Vicky M Coyle, Yvette Drew

Br J Cancer· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The role of vascular endothelial growth factor inhibitors in the treatment of epithelial ovarian cancer.
Alexander D Murphy, Robert D Morgan, Andrew R Clamp, Gordon C Jayson

Br J Cancer· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Psychosexual Morbidity in Women With Ovarian Cancer: Evaluation by Germline BRCA Gene Mutational Status.
Chloe A Logue, Julia Pugh, Philip Foden, Reem D Mahmood, Robert D Morgan, Gordon C Jayson

Sex Med· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
c-MET/VEGFR-2 co-localisation impacts on survival following bevacizumab therapy in epithelial ovarian cancer: an exploratory biomarker study of the phase 3 ICON7 trial.
Robert D Morgan, Cristina Ferreras, Isabel Peset, Egle Avizienyte, Andrew G Renehan, Gordon C Jayson

BMC Med· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and efficacy of the tumor-selective adenovirus enadenotucirev with or without paclitaxel in platinum-resistant ovarian cancer: a phase 1 clinical trial.
Victor Moreno, Maria-Pilar Barretina-Ginesta, Jesús García-Donas, Gordon C Jayson, Patricia Roxburgh

J Immunother Cancer· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of oxaliplatin plus 5-fluorouracil or capecitabine on circulating and imaging biomarkers in patients with metastatic colorectal cancer: a prospective biomarker study.
Reem D Mahmood, Danielle Shaw, Tine Descamps, Cong Zhou, Robert D Morgan, Gordon C Jayson

BMC Cancer· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Objective responses to first-line neoadjuvant carboplatin-paclitaxel regimens for ovarian, fallopian tube, or primary peritoneal carcinoma (ICON8): post-hoc exploratory analysis of a randomised, phase 3 trial.
Robert D Morgan, Iain A McNeish, Adrian D Cook, Elizabeth C James, Rosemary Lord, Gordon C Jayson

Lancet Oncol· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Image Contrast, Image Pre-Processing, and T Mapping Affect MRI Radiomic Feature Repeatability in Patients with Colorectal Cancer Liver Metastases.
Damien J McHugh, Nuria Porta, Ross A Little, Susan Cheung, Yvonne Watson, Gordon C Jayson

Cancers (Basel)· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Psychosexual morbidity in women with ovarian cancer.
Chloe Alice Logue, Julia Pugh, Gordon Jayson

Int J Gynecol Cancer· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis